Mesalazine in chronic idiopathic urticaria
Phase 2
- Conditions
- Chronic Idiopathic urticaria.Idiopathic Urticaria
- Registration Number
- IRCT138710041520N1
- Lead Sponsor
- Shiraz University of Medical Sciences - Vice Chancellor for Research Affairs
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Inclusion Criteria: new cases, the patients without proper control with antihistamines
Exclusion Criteria : children under 12y, pregnant ladies or women with breast feeding, underlying diseases, 5-ASA sensitivity, G6PD deficiency
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in Symptoms of the patients. Timepoint: 15 dayas and 1 month and 2 month. Method of measurement: Symptom Severity indices and Quality of Life Questionaire.
- Secondary Outcome Measures
Name Time Method Improvement in Quality of Life of the patients. Timepoint: 2 month. Method of measurement: Quality of life Questionaire.